» Articles » PMID: 28832034

Surface-modified Polymers for Cardiac Tissue Engineering

Overview
Journal Biomater Sci
Date 2017 Aug 24
PMID 28832034
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular disease (CVD), leading to myocardial infarction and heart failure, is one of the major causes of death worldwide. The physiological system cannot significantly regenerate the capabilities of a damaged heart. The current treatment involves pharmacological and surgical interventions; however, less invasive and more cost-effective approaches are sought. Such new approaches are developed to induce tissue regeneration following injury. Hence, regenerative medicine plays a key role in treating CVD. Recently, the extrinsic stimulation of cardiac regeneration has involved the use of potential polymers to stimulate stem cells toward the differentiation of cardiomyocytes as a new therapeutic intervention in cardiac tissue engineering (CTE). The therapeutic potentiality of natural or synthetic polymers and cell surface interactive factors/polymer surface modifications for cardiac repair has been demonstrated in vitro and in vivo. This review will discuss the recent advances in CTE using polymers and cell surface interactive factors that interact strongly with stem cells to trigger the molecular aspects of the differentiation or formulation of cardiomyocytes for the functional repair of heart injuries or cardiac defects.

Citing Articles

Advances in the design, generation, and application of tissue-engineered myocardial equivalents.

Bernava G, Iop L Front Bioeng Biotechnol. 2023; 11:1247572.

PMID: 37811368 PMC: 10559975. DOI: 10.3389/fbioe.2023.1247572.


Tissue Engineering Techniques for Induced Pluripotent Stem Cell Derived Three-Dimensional Cardiac Constructs.

Salem T, Frankman Z, Churko J Tissue Eng Part B Rev. 2021; 28(4):891-911.

PMID: 34476988 PMC: 9419978. DOI: 10.1089/ten.TEB.2021.0088.


Polymeric Biomaterials for the Treatment of Cardiac Post-Infarction Injuries.

Trombino S, Curcio F, Cassano R, Curcio M, Cirillo G, Iemma F Pharmaceutics. 2021; 13(7).

PMID: 34371729 PMC: 8309168. DOI: 10.3390/pharmaceutics13071038.


3D bioprinting in cardiac tissue engineering.

Wang Z, Wang L, Li T, Liu S, Guo B, Huang W Theranostics. 2021; 11(16):7948-7969.

PMID: 34335973 PMC: 8315053. DOI: 10.7150/thno.61621.


Can a Biohybrid Patch Salvage Ventricular Function at a Late Time Point in the Post-Infarction Remodeling Process?.

Silveira-Filho L, Coyan G, Adamo A, Luketich S, Menallo G, DAmore A JACC Basic Transl Sci. 2021; 6(5):447-463.

PMID: 34095634 PMC: 8165254. DOI: 10.1016/j.jacbts.2021.01.004.